RxDoctor Payments Data

Helen Bernie, DO

Urology · Indianapolis, INNPI 1477844637

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (48.2%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 61.3% of it on its own, with 12 other manufacturers making up the rest. 2025 is the largest year on record at $39,144, more than ten times the $1,801 reported in 2019. Among urology clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$100,129in general payments, 2019–2025

Across 258 payments — averaging $388.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$61K
  • Coloplast$33K
  • BK Medical Holding Company Inc.$4K
  • Endo Pharmaceuticals Inc.$983
  • KARL Storz Endoscopy-america$139
  • Laborie Medical Technologies Corp.$127
  • plus $330 from 7 others
$61,532in research payments, 2019–2025

Across 7 payments — averaging $8790.24 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Coloplast$48K
  • Endo USA, Inc.$14K

What the payments were for

  • Consulting fees$16,62517%
  • Speaking & faculty fees$48,23648%
  • Grants$2,0002%
  • Travel & lodging$23,47023%
  • Food & beverage$9,66910%
  • Education$1290%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$100,129 in reported general payments places this provider in the 95th percentile of 272 urology providers in Indiana.

See all urology providers in Indiana

Medicare billing

Part B allowed, 2024
$65,265
Medicare patients
143
Services billed
2,635

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim43$184
Fluconazole50$148

Paid to pharmacies, not to this prescriber.

Other urology in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →